TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)

$49.94 -0.03 (-0.06%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 62

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) News Sources

Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

17-09-2026

yahoo.com

Travere Therapeutics Announces Planned Chief Executive Officer Transition

21-09-2026

yahoo.com

Travere Therapeutics (TVTX) Sets CEO Handover For December 2026

23-09-2026

yahoo.com

Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis

23-09-2026

yahoo.com

Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026

02-10-2026

yahoo.com

Travere Therapeutics (TVTX) Is Down 6.7% After New FILSPARI Data And Patent Extension - What's Changed

07-10-2026

yahoo.com

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12-10-2026

yahoo.com

Earnings Preview: Travere Therapeutics (TVTX) Q3 Earnings Expected to Decline

22-10-2026

yahoo.com

Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy

23-10-2026

yahoo.com

Travere Therapeutics to Report Third Quarter 2026 Financial Results

26-10-2026

yahoo.com

TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) Sentiment Trend

0 25 50 75 100 85 80 88 59 80 33 62 2 52 75 17-09-2026 21-09-2026 23-09-2026 02-10-2026 07-10-2026 12-10-2026 22-10-2026 23-10-2026 26-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) FAQs

toggle

What is the current price of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?

The current price of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is $49.94.


toggle

TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) since the previous trading day is $-0.03.


toggle

TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) since the previous trading day is -0.06%.


toggle

What is the most recent average sentiment score for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?

The most recent average sentiment score for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is 62 out of 100.


toggle

What is the most recent average sentiment for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?

The most recent sentiment for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is .


SEC-8K** Filing Available For TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.